Blood-brain barrier drug discovery for central nervous system infections

Current Drug Targets - Infectious Disorders

Volumn 5, Issue 1, 2005, Pages 65-72

  Jong, Ambrose ^a   Huang, Sheng He ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Blood brain barrier; CNS infection; Drug discovery; Host defense; Infectomics; Microbial pathogens

Indexed keywords

AMPHOTERICIN B; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; CHOLINE; DEFENSIN; DIDANOSINE; FC RECEPTOR; GABAPENTIN; GLYCOCONJUGATE; GLYCOPROTEIN P; INSULIN RECEPTOR; LAMIVUDINE; LEPTIN RECEPTOR; LIPID; LIPOSOME; MELPHALAN; METHYLDOPA; MONOCLONAL ANTIBODY; MULTIDRUG RESISTANCE PROTEIN; ORGANIC ANION TRANSPORTER; PROTEOME; SOMATOMEDIN RECEPTOR; TRANSFERRIN RECEPTOR; VIRULENCE FACTOR; ZIDOVUDINE;

ACTIVE TRANSPORT; ANTIBIOTIC RESISTANCE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CENTRAL NERVOUS SYSTEM INFECTION; DRUG BRAIN LEVEL; DRUG DESIGN; DRUG FORMULATION; DRUG TARGETING; DRUG TRANSPORT; GENOMICS; GLYCOBIOLOGY; HUMAN; MOLECULAR WEIGHT; MYCOSIS; NONHUMAN; PROTEOMICS; REVIEW;

ANIMALS; ANTI-INFECTIVE AGENTS; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM INFECTIONS; DRUG DESIGN; HUMANS;

EID: 16344375600     PISSN: 15680053     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568005053174672     Document Type: Review

References (91)

1. Rubin, L.L.; Staddon, J.M. Ann. Rev. Neurosci. 1999 22, 11.
2. Ballabh, P.; Braun, A.; Nedergaard, M. Neurobiol. Disease 2004, 16, 1-13.
3. Misra, A.; Ganesh, S.; Shahiwala, A.; Shah, S.P. J. Pharm. Pharmaceu. Sci. 2003, 6, 252.
4. Fricker, G.; Miller, D.S. Pharmacol. 2004, 70 169.
5. Pardridge, W.M. Mol Interventions 2003, 3, 90.
6. Regina, A.; Demeule, M.; Laplante, A.; Jodoin, J.; Dagenais, C.; Berthelet, F.; Moghrabi, A.; Beliveau, R. Cancer Metastasis Rev. 2001, 20, 13.
7. Gonzalez-Mariscal, L.; Betanzos, A.; Nava, P.; Jaramillo, B.E. Prog. Biophys. Mol. Biol. 2003, 81, 1.
8. Schneeberger, E.E.; Lynch, R.D. Am. J. Physiol. - Cell Physiol. 2004, 286, C1213.
9. Lapierre, L.A.; Adv. Drug Delivery Rev. 2000, 41, 255.
10. Wolburg, H.; Lippoldt, A. Vascular Pharmacol. 2002 38, 323.
11. Chen, S.H. Stins, M.F. Huang, S.H. Chen, Y.H. Kwon-Chung, K.J.; Chang, Y.; Kim, K.S.; Suzuki, K.; Jong, A.Y. J. Med. Microbiol. 2003, 52, 961.
12. Zhang, J.R.; Tuomanen, E. J. Neurovirol. 1999, 5, 591.
13. Etienne-Manneville, S.; Manneville, J.B.; Adamson, P.; Wilbourn, B.; Greenwood, J.; Couraud, P.O. J. Immunol. 2000, 165, 3375.
14. Etienne, S.; Adamson, P.; Greenwood, J.; Strosberg, A.D.; Cazaubon, S.; Couraud, P.O. J. Immunol. 1998, 161, 5755.
15. Wittchen, E.S.; Haskins, J.; Stevenson, B.R. J. Biol. Chem. 1999, 274, 35179.
16. Sukumaran, S.K.; Prasadarao, N.V. J. Infect. Dis. 2003, 188, 1295.
17. Lee, S.W.; Kim, W.J.; Choi, Y.K.; Song, H.S.; Son, M.J.; Gelman, I.H.; Kim, Y.J.; Kim, K.W. Nature Medicine 2003, 9 900.
18. Janzer, R.C.; Raff, M.C. Nature 1987, 325, 253.
19. Merrill, J.E.; Murphy, S.P. Br. Behavior Immun. 1997 11, 245.
20. Braun, J.S.; Sublett, J.E.; Freyer, D.; Mitchell, T.J.; Cleveland, J.L.; Tuomanen, E.I.; Weber, J.R. J. Clin. Inv. 2002 109, 19.
21. Annunziata, P. J. Neurol. 2003, 250, 901.
22. Holmes, A.R.; McNab, R.; Millsap, K.W.; Rohde, M.; Hammerschmidt, S.; Mawdsley, J.L.; Jenkinson, H.F. Mol. Microbiol. 2001, 41, 1395.
23. Doran, K.S.; Liu, G.Y.; Nizet, V. J. Clin. Inv. 2003 112, 736.
24. Unkmeir, A.; Latsch, K.; Dietrich, G.; Wintermeyer, E.; Schinke, B.; Schwender, S.; Kim, K.S. Mol. Microbiol. 2002, 46, 933.
25. Chen, Y.H.; Chen, S.H.; Jong, A.; Zhou, Z.Y.; Li, W.; Suzuki, K.; Huang, S.H. Cell. Microbiol. 2002, 4, 503.
26. Hertzig, T.; Weber, M.; Greiffenberg, L.; Holthausen, B.S.; Goebel, W.; Kim, K.S.; Kuhn, M. Infect. Immun. 2003, 71 95.
27. Manning, S.D. Front. Biosci. 2003, 8, s1.
28. Wilson, S.L.; Drevets, D.A. J. Infect. Dis. 1998, 178, 1658.
29. Freyer, D.; Manz, R.; Ziegenhorn, A.; Weih, M.; Angstwurm, K.; Docke, W.D.; Meisel, A.; Schumann, R.R.; Schonfelder, G.; Dirnagl, U.; Weber, J.R. J. Immunol. 1999, 163, 4308.
30. Jong, A.Y.; Chen, S.H.; Stins, M.F.; Kim, K.S.; Tuan, T.L.; Huang, S.H. J. Med. Microbiol. 2003, 52, 615.
31. Jong, A.J.; Chen, S.H.; Stins, M.F.; Huang, S.H.; Kim, K.S. Infect. Immun. 2001, 69, 4536.
32. Chang, Y.C.; Stins, M.F.; McCaffery, M.J.; Miller, G.F.; Pare, D.R.; Dam, T.; Paul-Satyasee, M.; Kim, K.S.; Kwon-Chung, K.J. Infect. Immun. 2004, 72, 4985.
33. Liu, N.Q.; Lossinsky, A.S.; Popik, W.; Li, X.; Gujuluva, C.; Kriederman, B.; Roberts, J.; Pushkarsky, T.; Bukrinsky, M.; Witte, M.; Weinand, M.; Fiala, M. J. Virol. 2001, 76, 6689.
34. Seguin, R.; Biernacki, K.; Rotondo, R.L.; Prat, A.; Antel, J.P. J. Neuropathol. Exp. Neurol. 2003, 62, 412.
35. Dietrich, J.B. J. Neuroimmunol. 2002, 128, 58.
36. Unger, R.E.; Oltrogge, J.B.; von Briesen, H.; Engelhardt, B.; Woelki, U.; Schlote, W.; Lorenz, R.; Bratzke, H.; Kirkpatrick, C.J. In Vitro Cell. Devel. Biol. Animal 2002, 38, 273.
37. Jeliazkova-Mecheva, V.V.; Bobilya, D.J. Brain Res. 2003, 12, 91.
38. Stanness, K.A.; Westrum, L.E.; Fornaciari, E.; Mascagni, P.; Nelson, J.A.; Stenglein, S.G.; Myers, T.; Janigro, D. Brain Res. 1997, 771, 329.
39. Cecchelli, R.; Dehouck, B.; Descamps, L.; Fenart, L.; Buee-Scherrer, V.; Duhem, C.; Lundquist, S.; Rentfel, M.; Torpier, G.; Dehouck, M.P. Adv Drug Deliv Rev. 1999, 36, 165.
40. Terasaki, T.; Ohtsuki, S.; Hori, S.; Takanaga, H.; Nakashima, E.; Hosoya, K. Drug Discovery Today 2003, 8, 944.
41. Huang, S.H.; Wass, C.; Fu, Q.; Prasadarao, N.V.; Stins, M.; Kim, K.S. Infect. Immun. 1995, 63, 4470.
42. Berger, J.R.; Avison, M.; Front Biosci. 2004, 9, 2680.
43. Huang, S.H.; Jong, A.Y.; Cell. Microbiol. 2001, 3, 77.
44. Lipinski, C.A. J. Pharmacol. Toxicol. Methods 2000 44, 235.
45. May, E.L.; Jacobson, A.E. J. Pharm. Sci. 1997, 66, 285.
46. Yatin, M.B.; Li, W.; Meredith, M.J.; Shenoy, M.A. Adv. Drug Deliv. Rev. 1999, 39, 165.
47. Zhang, X.; Xie, J.; Li, S.; Wang, X.; Hou, X. J. Drug Target 2003, 11, 117.
48. Davey, R.A.; Davey, M.W.; Cullen, K.V.; Wells, X.E,; Francis, C.L.; Williams, H.M.; Yang, Q.; Moghaddam, M.J.; Widmer, F.; Whittaker, R.G. Br. J. Pharmacol. 2002, 137, 1280.
49. Unger, E.C.; Porter, T.; Culp, W.; Labell, R.; Matsunaga, T.; Zutshi, R. Adv Drug Deliv Rev. 2004, 56, 1291.
50. de Boer, A.G.; van der Sandt, I.C.; Gaillard, P.J. Ann. Rev. Pharmacol. Toxicol. 2003, 43, 629.
51. Scherrmann, J.M. Vascular Pharmacol. 2002, 38 349.
52. Tamai, I.; Tsuji, A. J. Pharmaceut. Sci. 2000, 89, 1371.
53. Matsuo, H.; Tsukada, S.; Nakata, T.; Chairoungdua, A.; Kim, D.K.; Cha, S.H.; Inatomi, J.; Yorifuji, H.; Fukuda, J.; Endou, H.; Kanai, Y. Neuroreport 2000, 11, 3507.
54. Killian, D.M.; Chikhale, P.J. J. Neurochem. 2001, 76, 966.
55. Uchino, H.; Kanai, Y.; Kim, K.; Wempe, M.F.; Chairoungdua, A.; Morimoto, E.; Anders, M.W.; Endou, H. Mol. Pharmacol. 2002 61, 729.
56. Sai, Y.; Tsuji, A. Drug Discov. Today 2004, 9 712.
57. Allen, D.D.; Lockman, P.R. Life Sci. 2003, 73 1609.
58. Allen, D.D.; Smith, Q.R. J. Neurochem. 2001, 76, 1032.
59. Lockman, P.R.; Allen, D.D. Drug Devel. Indust. Pharmacy 2002, 28, 749.
60. Begley, D.J. Curr. Pharmaceut. Design 2004, 10 1295.
61. Abe, T.; Koike, K.; Ohga, T.; Kubo, T.; Wada, M.; Kohno, K.; Mori, T.; Hidaka, K.; Kuwano, M. Br. J. Cancer 1995, 72 418.
62. Gao, B.; Stieger, B.; Noe, B.; Fritschy, J.M.; Meier, P.J. J. Histochem. Cytochem. 1999, 47, 1255.
63. Hagenbuch, B.; Meier, P.J. Biochim. Biophys. Acta 2003, 1609, 1.
64. Takasawa, K.; Terasaki, T.; Suzuki, H.; Sugiyama, Y.; J. Pharmacol Exp. Therapeutics 1997, 281, 369.
65. Huisman, M.T.; Smit, J.W.; Wiltshire, H.R.; Hoetelmans, R.M.; Beijnen, J.H.; Schinkel, A.H. Mol. Pharmacol. 2001, 59, 806.
66. de Boer, A.G.; van der Sandt, I.C.; Gaillard, P.J. Ann. Rev. Pharmacol. Toxicol. 2003, 43, 629.
67. Bultel-Brienne, S.; Lestavel, S.; Pilon, A.; Laffont, I.; Tailleux, A.; Fruchart, J.C.; Siest, G.; Clavey, V. J. Biol. Chem. 2002, 277, 36092.
68. Pardridge, W.M. Nature Reviews Drug Discovery 2002 1, 131
69. Pardridge, W.M. Curr. Opin. Invest. Drugs 2002, 3, 1753.
70. Huang, S.H.; Triche, T.; Jong, A.Y. Funct. Integ. Genomics 2002, 1, 331.
71. Chan, P.F.; Macarron, R.; Payne, D.J.; Zalacain, M.; Holmes, D.J. Curr. Drug Targets - Infect. Disorders 2002, 2, 291.
72. Cheng, Q.; Wang, S.; Salyers, A.A. Curr. Drug Targets - Infect. Disorders 2003, 3, 66.
73. Fritz, B.; Raczniak, G.A. Biodrugs 2002, 16 331.
74. Fitzgerald, J.R.; Sturdevant, D.E.; Mackie, S.M.; Gill, S.R.; Musser, J.M. Proc. Nat. Acad. Sci. USA 2001, 98, 8821.
75. Rosamond, J.; Allsop, A. Science 2000, 287, 1973.
76. Grifantini, R.; Bartolini, E.; Muzzi, A.; Draghi, M.; Frigimelica, E.; Berger, J.; Ratti, G.; Petracca, R.; Galli, G.; Agnusdei, M.; Giuliani, M.M.; Santini, L.; Brunelli, B.; Tettelin, H.; Rappuoli, R.; Randazzo, F.; Grandi, G. Nature Biotechnol. 2002 20, 914.
77. Rigden, D.J.; Galperin, M.Y.; Jedrzejas, M.J. Crit. Rev. Biochem. Mol. Biol. 2003, 38, 143.
78. Serruto, D.; Adu-Bobie, J.; Capecchi, B.; Rappuoli, R.; Pizza, M.; Masignani, V. J. Biotechnol. 2004, 113, 15.
79. Strausberg, R.L.; Schreiber, S.L. Science 2003, 300, 294.
80. Hanash, S. Nature 2003, 422, 226.
81. Speers, A.E.; Adam, G.C.; Cravatt, B.F. J. Am. Chem. Soc. 2003, 125, 4686.
82. Huang, S.H.; Jong, A.Y.; Summersgill, J.T. in "Handbook of Proteomic Studies" Ed. By Conn PM. Humana Press Inc., Totowa, New Jersey, 2003, pp.347.
83. Graves, P.R.; Haystead, T.A. Recent Prog. Hormone Res. 2003, 58, 1.
84. Delehanty, J.B.; Ligler, F.S.; Ligler, F.S. Anal. Chem. 2002, 74, 5681.
85. Walter, G.; Bussow, K.; Lueking, A.; Glokler, J. Trends Mol. Medicine 2002, 8, 250.
86. Zhang, L.; Yu, W.; He, T.; Yu, J.; Caffrey, R.E.; Dalmasso, E.A.; Fu, S.; Pham, T.; Mei, J.; Ho, J.J.; Zhang, W.; Lopez, P.; Ho, D.D. Science 2002, 298, 995.
87. Bacarese-Hamilton, T.; Bistoni, F.; Crisanti, A. Biotech. 2002, Suppl., 24.
88. Khersonsky, S.M.; Ho, C.M.; Garcia, M.A.; Chang, Y.T. Curr. Topics Med. Chem. 2003, 3, 617.
89. Wang, D.; Liu, S.; Trummer, B.J.; Deng, C.; Wang, A. Nature Biotechnol. 2002, 20, 275.
90. Hirabayashi, J. Trends Biotechnol. 2003, 21 141.
91. Seeberger, P.H. Chem. Commun. 2003, 10, 1115.